Background Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis in
foetal life. Researchers have recently attempted to use anti‐VEGF agents for the treatment of …

The treatment of ocular neovascular diseases is being revolutionized by intravitreal
therapies targeting vascular endothelial growth factor (VEGF). Two agents are approved for …

Importance Laser photocoagulation, which is the standard treatment for retinopathy of
prematurity (ROP), can have adverse events. Studies of anti–vascular endothelial growth …

Background—The recent discovery of circulating endothelial progenitor cells (EPCs) has
altered our understanding of new blood vessel growth such as occurs during collateral …

The leading causes of blindness are retinal and choroidal diseases manifesting abnormal
vessel permeability and growth. Scientists have sought to understand the mechanisms …

Vascular endothelial growth factor (VEGF-A) is a major pathogenic factor and a therapeutic
target for age-related macular degeneration, diabetic retinopathy, and retinopathy of …

Retinopathy of prematurity (ROP) has been recognised as an important cause of childhood
visual impairment and blindness since the 1940s when improved facilities and treatment …

Pathogenesis and treatment of bronchopulmonary dysplasia : Current Opinion in Pediatrics
Pathogenesis and treatment of bronchopulmonary dysplasia : Current Opinion in Pediatrics …

CONTEXT: Low oxygen saturation appears to decrease the risk of severe retinopathy of
prematurity (ROP) in preterm newborns when administered during the first few weeks after …

Constant oxygen supply is essential for proper tissue development, homeostasis and
function of all eukaryotic organisms. Cellular response to reduced oxygen levels is mediated …